Ethyl pyruvate therapy attenuates experimental severe arthritis caused by type II collagen (CII) in the mouse (CIA).

International journal of immunopathology and pharmacology

Volumn 23, Issue 4, 2010, Pages 1087-1098

  Di Paola, R ^a   Mazzon, E ^b   Galuppo, M ^b   Esposito, E ^b   Bramanti, P ^b   Fink, M P ^b   Cuzzocrea, S ^b  

^a IRCCS CENTRO NEUROLESI BONINO PULEJO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; COLLAGEN TYPE 2; CYTOKINE; HEME OXYGENASE 1; HMOX1 PROTEIN, MOUSE; INDUCIBLE NITRIC OXIDE SYNTHASE; MEMBRANE PROTEIN; NFE2L2 PROTEIN, MOUSE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADP RIBOSE)POLYMERASE 1, MOUSE; POLY(ADP-RIBOSE)POLYMERASE-1, MOUSE; PYRUVIC ACID DERIVATIVE; PYRUVIC ACID ETHYL ESTER; TRANSCRIPTION FACTOR NRF2;

ANIMAL; ARTHRITIS; ARTICLE; BLOOD; DBA MOUSE; IMMUNOLOGY; MALE; METABOLISM; MOUSE; NEUTROPHIL CHEMOTAXIS; PATHOLOGY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; CHEMOKINES; COLLAGEN TYPE II; CYTOKINES; HEME OXYGENASE-1; MALE; MEMBRANE PROTEINS; MICE; MICE, INBRED DBA; NEUTROPHIL INFILTRATION; NF-E2-RELATED FACTOR 2; NITRIC OXIDE SYNTHASE TYPE II; POLY(ADP-RIBOSE) POLYMERASES; PYRUVATES;

EID: 79953015315     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/039463201002300413     Document Type: Article

References (0)